Table of Contents Table of Contents 2 List of Tables 5 List of Figures 6 Introduction 7 Global Markets Direct Report Coverage 7 Alopecia Overview 8 Therapeutics Development 9 Pipeline Products for Alopecia - Overview 9 Pipeline Products for Alopecia - Comparative Analysis 10 Alopecia - Therapeutics under Development by Companies 11 Alopecia - Therapeutics under Investigation by Universities/Institutes 13 Alopecia - Pipeline Products Glance 14 Late Stage Products 14 Clinical Stage Products 15 Early Stage Products 16 Alopecia - Products under Development by Companies 17 Alopecia - Products under Investigation by Universities/Institutes 20 Alopecia - Companies Involved in Therapeutics Development 21 Ache Laboratorios Farmaceuticos S/A 21 Aclaris Therapeutics, Inc. 22 Allergan Plc 23 Almirall, S.A. 24 AndroScience Corporation 25 Berg LLC 26 BiologicsMD, Inc. 27 Bristol-Myers Squibb Company 28 Concert Pharmaceuticals, Inc. 29 Diffusion Pharmaceuticals Inc. 30 Follicum AB 31 Handok Inc. 32 Histogen, Inc. 33 Hyundai Pharmaceutical Co., Ltd. 34 Incyte Corporation 35 Kuhnil Pharmaceutical Co., Ltd. 36 Lee's Pharmaceutical Holdings Limited 37 LEO Pharma A/S 38 NovaLead Pharma Pvt. Ltd. 39 Novartis AG 40 Panacea Biotec Limited 41 Quark Pharmaceuticals, Inc. 42 RepliCel Life Sciences, Inc. 43 RXi Pharmaceuticals Corporation 44 Sucampo Pharmaceuticals, Inc. 45 SWITCH Biotech LLC 46 Taisho Pharmaceutical Holdings Co., Ltd. 47 TetraLogic Pharmaceuticals 48 Tigo GmbH 49 Valeant Pharmaceuticals International, Inc. 50 Vida Therapeutics Inc. 51 Alopecia - Therapeutics Assessment 52 Assessment by Monotherapy Products 52 Assessment by Target 53 Assessment by Mechanism of Action 56 Assessment by Route of Administration 59 Assessment by Molecule Type 61 Drug Profiles 63 abatacept - Drug Profile 63 Antibodies to Inhibit Heparanase for Alopecia, Colitis, Diabetic Nephropathy, Transplantation and Oncology - Drug Profile 68 Antisense Oligonucleotide to Antagonize Androgen Receptor for Alopecia - Drug Profile 69 ASCJ-9 - Drug Profile 70 ATI-50001 - Drug Profile 72 ATI-50002 - Drug Profile 73 bimatoprost - Drug Profile 74 BMD-1141 - Drug Profile 76 BMD-1341 - Drug Profile 77 BMD-2341 - Drug Profile 78 BQ-A - Drug Profile 79 BRM-421 - Drug Profile 80 calcitriol - Drug Profile 81 CB-0301 - Drug Profile 82 CTP-543 - Drug Profile 84 DHL-HisZnNa - Drug Profile 85 diphencyprone - Drug Profile 86 finasteride - Drug Profile 88 finasteride - Drug Profile 89 FOL-005 - Drug Profile 90 FS-2 - Drug Profile 93 Hair Stimulating Complex - Drug Profile 94 HL-5945 - Drug Profile 96 HTB-005 - Drug Profile 97 interferon beta-1b - Drug Profile 98 KI-1104 - Drug Profile 99 KI-1105 - Drug Profile 100 LEO-124249 - Drug Profile 101 minoxidil - Drug Profile 102 NLP-602 - Drug Profile 103 OLX-104 - Drug Profile 104 PDI-38 - Drug Profile 105 QPAL-1 - Drug Profile 106 QPAL-2 - Drug Profile 107 RCH-01 - Drug Profile 108 Recombinant Proteins to Antagonize IFN-Gamma Receptor 1 for Alopecia Areata and Graft Arteriosclerosis - Drug Profile 110 remetinostat - Drug Profile 111 RES-440 - Drug Profile 113 RK-023 - Drug Profile 115 ruxolitinib phosphate - Drug Profile 117 secukinumab - Drug Profile 129 setipiprant - Drug Profile 140 SM-04554 - Drug Profile 142 Small Molecule for Androgenic Alopecia - Drug Profile 144 Small Molecules to Inhibit JAK for Alopecia Areata and Androgenetic Alopecia - Drug Profile 145 Small Molecules to Inhibit JAK3 for Alopecia and Dermatological Disorders - Drug Profile 146 Synthetic Peptide for Alopecia - Drug Profile 147 TASP-0382088 - Drug Profile 148 VTI-1000 Series - Drug Profile 149 ZK-003 - Drug Profile 150 Alopecia - Dormant Projects 151 Alopecia - Discontinued Products 154 Alopecia - Product Development Milestones 155 Featured News & Press Releases 155 Appendix 163 Methodology 163 Coverage 163 Secondary Research 163 Primary Research 163 Expert Panel Validation 163 Contact Us 163 Disclaimer 164

List of Tables Number of Products under Development for Alopecia, H2 2016 13 Number of Products under Development for Alopecia - Comparative Analysis, H2 2016 14 Number of Products under Development by Companies, H2 2016 15 Number of Products under Development by Companies, H2 2016 (Contd..1) 16 Number of Products under Investigation by Universities/Institutes, H2 2016 17 Comparative Analysis by Late Stage Development, H2 2016 18 Comparative Analysis by Clinical Stage Development, H2 2016 19 Comparative Analysis by Early Stage Development, H2 2016 20 Products under Development by Companies, H2 2016 21 Products under Development by Companies, H2 2016 (Contd..1) 22 Products under Development by Companies, H2 2016 (Contd..2) 23 Products under Investigation by Universities/Institutes, H2 2016 24 Alopecia - Pipeline by Ache Laboratorios Farmaceuticos S/A, H2 2016 25 Alopecia - Pipeline by Aclaris Therapeutics, Inc., H2 2016 26 Alopecia - Pipeline by Allergan Plc, H2 2016 27 Alopecia - Pipeline by Almirall, S.A., H2 2016 28 Alopecia - Pipeline by AndroScience Corporation, H2 2016 29 Alopecia - Pipeline by Berg LLC, H2 2016 30 Alopecia - Pipeline by BiologicsMD, Inc., H2 2016 31 Alopecia - Pipeline by Bristol-Myers Squibb Company, H2 2016 32 Alopecia - Pipeline by Concert Pharmaceuticals, Inc., H2 2016 33 Alopecia - Pipeline by Diffusion Pharmaceuticals Inc., H2 2016 34 Alopecia - Pipeline by Follicum AB, H2 2016 35 Alopecia - Pipeline by Handok Inc., H2 2016 36 Alopecia - Pipeline by Histogen, Inc., H2 2016 37 Alopecia - Pipeline by Hyundai Pharmaceutical Co., Ltd., H2 2016 38 Alopecia - Pipeline by Incyte Corporation, H2 2016 39 Alopecia - Pipeline by Kuhnil Pharmaceutical Co., Ltd., H2 2016 40 Alopecia - Pipeline by Lee's Pharmaceutical Holdings Limited, H2 2016 41 Alopecia - Pipeline by LEO Pharma A/S, H2 2016 42 Alopecia - Pipeline by NovaLead Pharma Pvt. Ltd., H2 2016 43 Alopecia - Pipeline by Novartis AG, H2 2016 44 Alopecia - Pipeline by Panacea Biotec Limited, H2 2016 45 Alopecia - Pipeline by Quark Pharmaceuticals, Inc., H2 2016 46 Alopecia - Pipeline by RepliCel Life Sciences, Inc., H2 2016 47 Alopecia - Pipeline by RXi Pharmaceuticals Corporation, H2 2016 48 Alopecia - Pipeline by Sucampo Pharmaceuticals, Inc., H2 2016 49 Alopecia - Pipeline by SWITCH Biotech LLC, H2 2016 50 Alopecia - Pipeline by Taisho Pharmaceutical Holdings Co., Ltd., H2 2016 51 Alopecia - Pipeline by TetraLogic Pharmaceuticals, H2 2016 52 Alopecia - Pipeline by Tigo GmbH, H2 2016 53 Alopecia - Pipeline by Valeant Pharmaceuticals International, Inc., H2 2016 54 Alopecia - Pipeline by Vida Therapeutics Inc., H2 2016 55 Assessment by Monotherapy Products, H2 2016 56 Number of Products by Stage and Target, H2 2016 58 Number of Products by Stage and Mechanism of Action, H2 2016 61 Number of Products by Stage and Route of Administration, H2 2016 64 Number of Products by Stage and Molecule Type, H2 2016 66 Alopecia - Dormant Projects, H2 2016 155 Alopecia - Dormant Projects (Contd..1), H2 2016 156 Alopecia - Dormant Projects (Contd..2), H2 2016 157 Alopecia - Discontinued Products, H2 2016 158 List of Figures Number of Products under Development for Alopecia, H2 2016 13 Number of Products under Development for Alopecia - Comparative Analysis, H2 2016 14 Number of Products under Development by Companies, H2 2016 15 Number of Products under Investigation by Universities/Institutes, H2 2016 17 Comparative Analysis by Late Stage Development, H2 2016 18 Comparative Analysis by Clinical Stage Development, H2 2016 19 Comparative Analysis by Early Stage Products, H2 2016 20 Assessment by Monotherapy Products, H2 2016 56 Number of Products by Top 10 Targets, H2 2016 57 Number of Products by Stage and Top 10 Targets, H2 2016 57 Number of Products by Top 10 Mechanism of Actions, H2 2016 60 Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016 60 Number of Products by Routes of Administration, H2 2016 63 Number of Products by Stage and Routes of Administration, H2 2016 63 Number of Products by Top 10 Molecule Types, H2 2016 65 Number of Products by Stage and Top 10 Molecule Types, H2 2016 65

Ache Laboratorios Farmaceuticos S/A Aclaris Therapeutics, Inc. Allergan Plc Almirall, S.A. AndroScience Corporation Berg LLC BiologicsMD, Inc. Bristol-Myers Squibb Company Concert Pharmaceuticals, Inc. Diffusion Pharmaceuticals Inc. Follicum AB Handok Inc. Histogen, Inc. Hyundai Pharmaceutical Co., Ltd. Incyte Corporation Kuhnil Pharmaceutical Co., Ltd. Lee's Pharmaceutical Holdings Limited LEO Pharma A/S NovaLead Pharma Pvt. Ltd. Novartis AG Panacea Biotec Limited Quark Pharmaceuticals, Inc. RepliCel Life Sciences, Inc. RXi Pharmaceuticals Corporation Sucampo Pharmaceuticals, Inc. SWITCH Biotech LLC Taisho Pharmaceutical Holdings Co., Ltd. TetraLogic Pharmaceuticals Tigo GmbH Valeant Pharmaceuticals International, Inc. Vida Therapeutics Inc.